Cystadrops 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
R/0022 
Renewal of the marketing authorisation. 
22/07/2021 
15/09/2021 
SmPC, 
Labelling and 
PL 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
02/09/2021 
n/a 
PRAC Recommendation - maintenance 
/202101 
mercaptamine (treatment of corneal cystine) 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
IB/0020 
B.II.b.4.a - Change in the batch size (including batch 
15/10/2020 
n/a 
size ranges) of the finished product - Up to 10-fold 
compared to the originally approved batch size 
IB/0019 
B.II.e.5.a.2 - Change in pack size of the finished 
23/09/2020 
15/09/2021 
SmPC, Annex 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
II, Labelling 
and PL 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
03/09/2020 
n/a 
PRAC Recommendation - maintenance 
/202001 
mercaptamine (treatment of corneal cystine) 
N/0017 
Minor change in labelling or package leaflet not 
26/05/2020 
15/09/2021 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0016 
B.I.b.2.a - Change in test procedure for AS or 
24/03/2020 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
05/09/2019 
n/a 
PRAC Recommendation - maintenance 
/201901 
mercaptamine (treatment of corneal cystine) 
IG/1085/G 
This was an application for a group of variations. 
16/05/2019 
04/05/2020 
SmPC, Annex 
A.1 - Administrative change - Change in the name 
and/or address of the MAH 
A.5.a - Administrative change - Change in the name 
and/or address of a manufacturer/importer 
responsible for batch release 
A.5.a - Administrative change - Change in the name 
II, Labelling 
and PL 
Page 2/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and/or address of a manufacturer/importer 
responsible for batch release 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
N/0013 
Minor change in labelling or package leaflet not 
22/02/2019 
04/05/2020 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
14/02/2019 
n/a 
PRAC Recommendation - maintenance 
/201807 
mercaptamine (treatment of corneal cystine) 
IB/0012/G 
This was an application for a group of variations. 
15/01/2019 
n/a 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
(including replacement or addition) 
IA/0011/G 
This was an application for a group of variations. 
19/12/2018 
n/a 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
Page 3/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
N/0009 
Minor change in labelling or package leaflet not 
07/11/2018 
04/05/2020 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
06/09/2018 
n/a 
PRAC Recommendation - maintenance 
/201801 
mercaptamine (treatment of corneal cystine) 
N/0007 
Minor change in labelling or package leaflet not 
30/05/2018 
04/05/2020 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
IB/0006/G 
This was an application for a group of variations. 
08/03/2018 
n/a 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
PSUSA/10574
Periodic Safety Update EU Single assessment - 
08/02/2018 
n/a 
PRAC Recommendation - maintenance 
/201707 
mercaptamine (treatment of corneal cystine) 
IA/0003/G 
This was an application for a group of variations. 
11/09/2017 
n/a 
B.II.b.5.a - Change to in-process tests or limits 
Page 4/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
applied during the manufacture of the finished 
product - Tightening of in-process limits 
B.II.b.5.c - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Deletion of a non-significant in-process test 
B.II.b.5.c - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Deletion of a non-significant in-process test 
IA/0002/G 
This was an application for a group of variations. 
10/08/2017 
n/a 
B.II.b.5.a - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Tightening of in-process limits 
B.II.b.5.c - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Deletion of a non-significant in-process test 
IAIN/0001/G 
This was an application for a group of variations. 
16/02/2017 
11/01/2018 
Annex II and 
PL 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
Page 5/5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
